Indian pharma industry estimated to grow 9-11% in 2021-22: ICRA, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

“Revenue growth for ICRA sample set is estimated at 9-11 per cent in FY2022 and in FY2023, supported by gradual recovery post the impact of COVID-19,” ICRA Assistant Vice-President and Sector Head Mythri Macherla said., “Revenue growth for ICRA sample set is estimated at 9-11 per cent in FY2022 and in FY2023, supported by gradual recovery post the impact of COVID-19,” ICRA Assistant Vice-President and Sector Head Mythri Macherla said., , Read More